BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7982240)

  • 1. Mammography screening controversies.
    Miller AB
    Cancer Detect Prev; 1994; 18(4):305-11. PubMed ID: 7982240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Canadian National Breast Screening Study. Why? What next? And so what?
    Baines CJ
    Cancer; 1995 Nov; 76(10 Suppl):2107-12. PubMed ID: 8635008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer.
    Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening mammography controversies: resolved, partly resolved, and unresolved.
    Feig SA
    Breast J; 2005; 11 Suppl 1():S3-6. PubMed ID: 15725113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is routine mammography screening appropriate for women 40-49 years of age?
    Miller AB
    Am J Prev Med; 1991; 7(1):55-62. PubMed ID: 1867901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey.
    Sabatino SA; Burns RB; Davis RB; Phillips RS; Chen YH; McCarthy EP
    Cancer; 2004 Jun; 100(11):2338-46. PubMed ID: 15160336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mammography use among Canadian women aged 50-69: findings from the 1996/97 National Population Health Survey.
    Maxwell CJ; Bancej CM; Snider J
    CMAJ; 2001 Feb; 164(3):329-34. PubMed ID: 11232132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast cancer].
    Fukuda M; Miyamoto K; Hashizume R; Okamoto J; Kawamoto H; Yabuki Y; Ogata H; Ohta T
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1900-6. PubMed ID: 12465388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening: recent trends in the use of mammography in Nebraska.
    Rettig B; Nelson N; Faulk R
    Nebr Med J; 1994 May; 79(5):136-8; discussion 139. PubMed ID: 8047188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The control of breast cancer through mammography screening. What is the evidence?
    Tabár L; Dean PB
    Radiol Clin North Am; 1987 Sep; 25(5):993-1005. PubMed ID: 3306777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of breast cancer screening.
    Pisano ED; McLelland R
    Curr Opin Radiol; 1991 Aug; 3(4):579-87. PubMed ID: 1909543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.